Mark A Hughes

Title: Innovations by Mark A. Hughes in Trichomoniasis Diagnostics

Introduction

Mark A. Hughes is an accomplished inventor based in Morgan Hill, CA (US). He has made significant contributions to the field of diagnostics, particularly in the detection of trichomoniasis. With a total of 2 patents, Hughes has developed innovative methods that enhance the accuracy and reliability of diagnostic tests.

Latest Patents

Hughes' latest patents focus on assays for trichomonal and other hydrolases. These patents describe a selective diagnostic assay for trichomoniasis that measures the hydrolysis of specific substrates by vaginal fluid at a low pH. The method ensures that the results are not interfered with by unrelated hydrolases. Additionally, selective assays can be obtained by removing particulate matter from vaginal fluid samples, allowing for the extraction of a fraction devoid of larger particles. This extracted fraction can be combined with specified hydrolase inhibitors and tested for enzymatic activity. The innovations in these patents lead to a series of diagnostic tests and devices that provide results detectable by visual and other means with high accuracy.

Career Highlights

Hughes is currently associated with Quidel Corporation, a company known for its advancements in diagnostic testing. His work has been pivotal in developing reliable diagnostic tools that address critical health issues.

Collaborations

Some of his notable coworkers include Paul J. Lawrence and Aulena Chaudhuri, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Mark A. Hughes continues to be a significant figure in the field of diagnostics, particularly for trichomoniasis. His innovative patents and contributions to Quidel Corporation highlight his commitment to improving healthcare through advanced diagnostic solutions.